Cargando…

Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIV

Coevolution of microbiome and immunity at mucosal sites is essential for our health. Whether the oral microbiome, the second largest community after the gut, contributes to the immunogenicity of COVID-19 vaccines is not known. We investigated the baseline oral microbiome in individuals in the COVAXI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghorbani, Mahin, Al-Manei, Khaled, Naud, Sabrina, Healy, Katie, Gabarrini, Giorgio, Sobkowiak, Michal Jacek, Chen, Puran, Ray, Shilpa, Akber, Mira, Muschiol, Sandra, Bogdanovic, Gordana, Bergman, Peter, Ljungman, Per, Buggert, Marcus, Ljunggren, Hans-Gustaf, Pin, Elisa, Nowak, Piotr, Aleman, Soo, Sällberg Chen, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871925/ https://www.ncbi.nlm.nih.gov/pubmed/36703980 http://dx.doi.org/10.3389/fimmu.2022.1079995

Ejemplares similares

Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals
por: Healy, Katie, et al.
Publicado: (2022)

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID
por: Chen, Puran, et al.
Publicado: (2023)

Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia
por: Andersson, Maria, et al.
Publicado: (2023)

Clinical Microbial Identification of Severe Oral Infections by MALDI-TOF Mass Spectrometry in Stockholm County: an 11-Year (2010 to 2020) Epidemiological Investigation
por: Al-Manei, Khaled, et al.
Publicado: (2022)

NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals
por: Cuapio, Angelica, et al.
Publicado: (2022)

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
por: Bergman, Peter, et al.
Publicado: (2021)

Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination
por: Blixt, Lisa, et al.
Publicado: (2022)

Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination
por: Gao, Yu, et al.
Publicado: (2022)

SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants
por: Lindahl, Hannes, et al.
Publicado: (2023)

T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial
por: Blixt, Lisa, et al.
Publicado: (2022)

Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant
por: Lindahl, Hannes, et al.
Publicado: (2022)

Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy
por: Alkharaan, Hassan, et al.
Publicado: (2020)

Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys
por: Alkharaan, Hassan, et al.
Publicado: (2021)

Correction to: Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys
por: Alkharaan, Hassan, et al.
Publicado: (2022)

MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine
por: Boulouis, Caroline, et al.
Publicado: (2022)

Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients
por: Blixt, Lisa, et al.
Publicado: (2021)

Chronic Viral Liver Diseases: Approaching the Liver Using T Cell Receptor-Mediated Gene Technologies
por: Healy, Katie, et al.
Publicado: (2020)

Elevated CD21(low) B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency
por: Bergman, Peter, et al.
Publicado: (2022)

Expansion of donor-unrestricted MAIT cells with enhanced cytolytic function suitable for TCR redirection
por: Parrot, Tiphaine, et al.
Publicado: (2021)

SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation
por: Sandberg, John Tyler, et al.
Publicado: (2021)

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant
por: Gao, Yu, et al.
Publicado: (2022)

Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions
por: Healy, Katie, et al.
Publicado: (2021)

Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox
por: Adamo, Sarah, et al.
Publicado: (2023)

Isolation of pancreatic microbiota from cystic precursors of pancreatic cancer with intracellular growth and DNA damaging properties
por: Halimi, Asif, et al.
Publicado: (2021)

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
por: Sekine, Takuya, et al.
Publicado: (2020)

Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell Products
por: Silva, Daniela Nascimento, et al.
Publicado: (2022)

Editorial: HBV—the naked truth?
por: Pasetto, Anna, et al.
Publicado: (2019)

Unique transcriptional and protein-expression signature in human lung tissue-resident NK cells
por: Marquardt, Nicole, et al.
Publicado: (2019)

Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity
por: Kvedaraite, Egle, et al.
Publicado: (2021)

COVID‐19‐specific metabolic imprint yields insights into multiorgan system perturbations
por: Cornillet, Martin, et al.
Publicado: (2021)

Nonsurgical endodontic management of mandibular first premolar with incomplete root‐end resection
por: Al‐Manei, Khaled, et al.
Publicado: (2020)

Functional SARS-CoV-2 cross-reactive CD4(+) T cells established in early childhood decline with age
por: Humbert, Marion, et al.
Publicado: (2023)

Paths taken towards NK cell–mediated immunotherapy of human cancer—a personal reflection
por: Ljunggren, Hans‐Gustaf
Publicado: (2020)

Evaluation of 11 SARS-CoV-2 antibody tests by using samples from patients with defined IgG antibody titers
por: Lagerqvist, Nina, et al.
Publicado: (2021)

Tissue‐resident MAIT cell populations in human oral mucosa exhibit an activated profile and produce IL‐17
por: Sobkowiak, Michał J., et al.
Publicado: (2018)

Does time heal all wounds? A longitudinal study of the development of posttraumatic stress symptoms in parents of survivors of childhood cancer and bereaved parents
por: Ljungman, Lisa, et al.
Publicado: (2015)

Internet‐based guided self‐help for parents of children on cancer treatment: a randomized controlled trial
por: Cernvall, Martin, et al.
Publicado: (2015)

Probabilistic classification of anti‐SARS‐CoV‐2 antibody responses improves seroprevalence estimates
por: Castro Dopico, Xaquin, et al.
Publicado: (2022)

Functional Aspects of Intrahepatic Hepatitis B Virus-specific T Cells Induced by Therapeutic DNA Vaccination
por: Brass, Anette, et al.
Publicado: (2015)

Activated Natural Killer Cells Hit Neurogenesis in the Aging Brain
por: Cuapio, Angelica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bm2cplvesbqf34eihnqaeg83q6